With the recent surge in demand for personalized and high-precision
medical services, services aimed at preventing and treating diseases
based on genetic information have become a means to improve
the quality of life.
Of particular note, the non-clinical and clinical bio outsourcing market is
growing rapidly for bringing about enhanced efficiency and specialized
services in the pharmaceutical industry.

Armed with more than 10 years of experience in pharmacogenomic research,
non-clinical ADME assessments and clinical trials, as well as outstanding
technology, SPMED Co., Ltd. plans to commercialize and popularize its
quality products and services in the healthcare and pharmaceutical sectors
instead of confining them to research. At SPMED, we promise to fulfill
our social responsibilities by making relentless efforts toward
positive change.